Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REThink Chronic-A Mobile Therapeutic Game for the Prevention of Emotional Disorders Among Children Aged 8-16 Years With a Chronic Physical Disease

NCT05163938 is registered in ClinicalTrials.gov with Babes-Bolyai University as lead sponsor.

NCT NCT05163938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05163938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REThink Chronic-A Mobile Therapeutic Game for the Prevention of Emotional Disorders Among Children Aged 8-16 Years With a Chronic Physical Disease
Lead sponsor
Babes-Bolyai University
Phase
Not applicable
Overall status
Unknown status
Start date
January 10, 2022
Completion date
June 1, 2025
Enrollment
158 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rethink game, treatment-as-usual